Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2022-03-08 Proxy Solicitation & In…
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often associated with the DART system) used to solicit shareholder votes for an upcoming Annual General Meeting. It contains details about the meeting, the proxy solicitation process, and includes financial statements as supporting information for the shareholders. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2022-03-08 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for MedPacto. It outlines the date, location, and specific agenda items (financial statement approval, director/auditor appointments, and stock option grants). This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2022-03-04 Korean
기타경영사항(자율공시)(전환우선주의 보통주 전환)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from MedPacto regarding the conversion of convertible preferred shares into common shares. It details the number of shares converted, the conversion ratio, the impact on capital structure, and the issuance of new common shares. This type of corporate action, involving changes to the company's share capital structure, is best classified as a Share Issue/Capital Change (SHA).
2022-02-18 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) presentation/conference call. It specifies the date, time, purpose, and method of the event, and directs readers to the KRX KIND system to access the actual presentation materials on the day of the event. Since this is an announcement of an event rather than the presentation deck itself, and it serves as a regulatory notification of corporate activity, it fits the criteria for a Regulatory Filing (RNS) or a general announcement.
2022-02-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (MedPacto) announcing a significant change in financial structure (specifically a 30% or greater change in profit/loss). This is a standard disclosure requirement for publicly traded companies in Korea (DART system) when financial results deviate significantly from the previous period. Since it provides key financial highlights (operating profit, net income, assets, liabilities) as an initial announcement before the final audit report, it fits the definition of an Earnings Release (ER). FY 2021
2022-02-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a director (Kim Seong-jin) of MedPacto. This type of filing is a standard regulatory requirement for insider trading or changes in ownership by company directors, which corresponds to the 'Director's Dealing' category.
2022-01-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.